Yield Basis (YB/IDR) Price Today
Aura AI Summary
Key Stats
- Rp179MMarket Cap
- Rp73,24MVolume (24h)
- 132,5M / 1B YB (14%)Circulating Supply
- 57% Sell | 43% BuyTrading Activity
- 5 DaysTypical Hold Time
Track Yield Basis price today on Pluang, updated in real time with live charts and market data. Yield Basis currently has a market capitalization of Rp179M and a 24-hour trading volume of Rp73,24M. Yield Basis has traded between an all-time low of Rp1,170.21 and an all-time high of Rp15,590.56. The circulating supply of Yield Basis stands at 132,5M / 1B YB (14%). Recent trading activity shows 57% Sell and 43% Buy, highlighting current market sentiment. On average, investors hold Yield Basis for approximately 5 Days. Buy and sell Yield Basis on Pluang — a safe, fast, and OJK-regulated way to invest in crypto.
About Yield Basis
YieldBasis is a DeFi protocol built on Curve Finance that enables users to earn yield on assets like Bitcoin while minimizing impermanent loss. It uses a constant 2× compounding leverage model to help LP positions track the underlying asset price 1:1. The YB token supports governance through a vote-escrowed (veYB) model and allows holders to share in protocol revenue.
Order Book
Shows real-time buy and sell orders, market depth, and short-selling activity to help investors gauge market sentiment.
Most Recent News
Eos Energy posts record Q2 revenue of $68-69M, with order backlog hitting $807M, doubling production capacity.
Eos Energy reported its strongest quarter ever with Q2 2026 revenue projected between $68 million and $69 million, surpassing its full-year 2025 revenue in just the first half of 2026. The company’s order backlog reached an all-time high of $807 mill...

PENGU token unlocks 0.8% supply on July 17, testing market liquidity amid brand strength.
On July 17, 722.96 million PENGU tokens, about 0.8% of total supply, will unlock, potentially impacting market liquidity and price. Previous unlocks, like June 17, caused a 20.6% price drop over ten days, showing supply shocks can influence price if ...

Abbott shares rise 4% as Q2 earnings beat estimates, driven by strong diagnostics growth.
Abbott Laboratories reported better-than-expected Q2 results with adjusted EPS of $1.31 surpassing estimates of $1.28 and revenue rising 13% to $12.59 billion. The diagnostics segment led growth with a 42% surge, fueled by the acquisition of Exact Sc...
